Kestra Medical Technologies, Ltd. KMTS
26.63 USD -1.66 (-5.87%)
Regular-session close
26.63 0.00 0.00%
After hours · Nov 19, 4:01 PM ET
26.34 Day range 28.48
17.34 52-week range 31.99
- YTD
- +0.41%
- 1 year
- +3.10%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 31.13 +16.9% upside
Now 26.63
- Target (low)
- 28.00
- Target (mean)
- 31.13
- Target (high)
- 34.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy2
- Buy6
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 8
- 3 months ago 8
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.605 | -0.61 – -0.60 | -0.4493 | -34.6% | 32.09M | +42.2% | 2 |
| Next quarter | -0.575 | -0.58 – -0.57 | -0.4042 | -42.3% | 35.49M | +44.5% | 2 |
| Current year | -2.45 | -2.46 – -2.44 | -1.71 | -43.4% | 140.85M | +48.1% | 2 |
| Next year | -2.06 | -2.06 – -2.05 | -2.45 | +16.1% | 195.99M | +39.2% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| Sep 15, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 2, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 10, 2026 | JP Morgan | Initiated | — | Overweight |
| Jul 21, 2026 | Oppenheimer | Initiated | — | Perform |
| Jul 15, 2026 | BTIG | Maintained | Buy | Buy |
| Apr 9, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Apr 7, 2026 | BTIG | Reiterated | Buy | Buy |
| Mar 25, 2026 | BTIG | Reiterated | Buy | Buy |
| Mar 18, 2026 | BTIG | Reiterated | Buy | Buy |
| Dec 15, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Dec 12, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Dec 12, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 18, 2025 | BTIG | Initiated | — | Buy |
| Jul 17, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 16, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Mar 31, 2025 | Wolfe Research | Initiated | — | Outperform |
| Mar 31, 2025 | Wells Fargo | Initiated | — | Overweight |
| Mar 31, 2025 | Stifel | Initiated | — | Buy |
| Mar 31, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Mar 31, 2025 | Piper Sandler | Initiated | — | Overweight |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
